Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
KP.3.2.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.4.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.3.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.3.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.3.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.65.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.65.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.65.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LF.1.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LF.1.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.1.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDVNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDVNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDVNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KS.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KS.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KS.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MK.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
MK.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1212.29Singapore
MK.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.4.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LB.1.7.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LB.1.7.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LB.1.7.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.42.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.42.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.42.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LA.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LA.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LA.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
LF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
LF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KP.2.16NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KP.2.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KP.2.16NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDV.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used